Trial Profile
Endocrine with or without Surgical therapy for Elderly women with Mammary cancer.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 29 Jul 2017
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms ESTEeM
- 30 Jan 2014 Study status changed to discontinued.
- 02 Dec 2011 Additional lead trial centre and investigator identified as reported by United Kingdom Clinical Research Network record.
- 02 Dec 2011 New source identified and integrated (United Kingdom Clinical Research Network: 2066).